Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I've been wondering about that myself?
Is this still alive? There used to be a time when they used to put out occasional news, that's how they trapped me into buying this bag when it was rising.
Sounds good, thx
wow ! I just found this stock, it is sweet - thinking on jumping in for the ride -- any advice ?
thx --- that sounds sweet - I hope so
Data results from the trials is what institutional investors look for, but is good to have the occasional news out. I think that the announcement of Dr. Matthias Lohr is monumental. This cell-in-box with ifosfamide treatments may revolutionize medicine.
Are there any more aamrq distributions coming in the future?
05/01/2014 Top Five Stocks Focus List: Avanir Pharmaceuticals, Inc. Ins Pro Technologies Corp, Elite Pharmaceuticals, Inc. Nuvilex, Inc. Tranzbyte Corporation
http://www.marketwatch.com/m/story/a496bb2e-3aa2-4382-bc03-c2c1ac6fd8f2
How can anyone short, it's been consistently losing for a week?
I thought that there was a phase trial report today?
PDF:
Austrianova contracted by Nuvilex Inc. for cGMP-Compliant Cell-in-a-Box® Encapsulation of Cells
From: http://austrianova.com/wp-content/uploads/2014/03/Austrianova-contracted-by-Nuvilex-Inc.pdf
Press Relase- March 21st, 2014
Austrianova contracted by Nuvilex Inc. for cGMP-Compliant Cell-in-a-Box® Encapsulation of Cells
Singapore, March 21st, 2014
Austrianova, a leading cell encapsulation company, announced today that it has been contracted by Nuvilex, Inc. to produce living encapsulated cells to cGMP (Good Manufacturing Practices) standard. The two companies signed a Manufacturing Framework Agreement that covers all aspects of the production of the encapsulated live cells. The encapsulated cells, also known as Cell-in-a-Box®, will be used for Nuvilex’s preclinical studies and clinical trials in patients with pancreatic cancer and other types of cancer.
Please <click here> to access the full Press Release including an interviews with Austrianova’s Chairman, Prof Walter H. Gunzburg and Austrianova’s CEO, Brian Salmons.
http://austrianova.com/press-relase-march-21st-2014/
"Cell in the Box" by "SG Austria"
"...SG Austria is a life science service based company specialising in the enclosure of living cells or bacteria in small capsules (encapsulation) for protection, isolation, storage and transportation. The Cell-in-a-Box and Bac-in-a-Box technologies are unique and use proprietry materials. The technology is being used in the biotech, biomed, nutrition, farming, veterinary, environmental and cosmetics industries.
SG Austria (operating under Austrianova Singapore Pte Ltd), was established in 2007; whilst based in Singapore’s top research biotech hub, Biopolis, it has a global footprint. In addition to offering Cell-in-a-Box and Bac-in-a-Box business to business, SG Austria is also developing it's own oncology product which has already been in multiple, sucessful clinical trials. SG Austria also provides services around the GMP manufacturing of encapsulated cell products..."
From:
https://www.pharmatching.com/company/sg-austria-pte-ltd-operating-austrianova-singapore-pte-ltd
Company URL: http://austrianova.com/ Cell in the Box Contracted by Nuvilex
http://austrianova.com/?s=nuvilex
Some positive phase trial news directly from the company will be explosive here.
Probably a pump-and-dump somewhere. I've been carrying this dead bag for a while. THEY used to about 2 years put out some news for shareholders from time to time.
The news was that they may have a situation that may be favorable to quick approval status, nothing more, but, it may also be indicating that phase trials are going well, which would be the explosive news we look for in any biotech stock..
04/22/2014 LONDON, April 22, 2014 /PRNewswire/ --
"...Five Small Caps Focus List..."
Nuvilex (OTC: NVLX) was a new name being followed on the volume watch list with shares trading flat on the day with below average volume. Nuvilex had more than $1.6 million exchange hands in a strong days trading in the company as it looks to rise higher to resistance.
04/23/2014 nvlx - mixed news, see link: http://www.hotstocked.com/article/82352/nuvilex-inc-otcmkts-nvlx-moves-up-on-paid.html
How many patients are currently enrolled in the pancreatic trials ? Does anybody know?
So what? They are informing investors, keeping the stock alive and active.
The news about KING entering the Chinese market is huge.
Having Dr. William P. Murphy, Jr as chairman of the board who is the founder of Cordis which was bought by Johnson & Johnson is a big plus.
Nice promo video:
Do you have link to that?
I see a lot of "will partner up" news, a lot of "will be" news.
Where are the data numbers from these phase trials?
Well, like many here I was up about 4k last week, i sold in red today, but we'll be back for sure.
I'm out at .27 had no choice, I waited till 1,200. In red, too much to continue to risk for now. I'll keep eye on it, I'm sure I'll be back.
I'm out at .27 had no choice, i waited till 1,200. In red, too much to continue to risk for now. I'll keep eye on it, I'm sure I'll be back.
I'm puzzled as to what is spooking investors here, this is a little stock with huge potential outcomes.
Clinical Network Services
http://www.clinical.net.au/
This is one of the most profitable corporations in America right now, don't understand this downturn.
I believe that when update news comes out about the stage 2 work soon commencing with "ViruSure GmbH, in Vienna, Austria, to develop and maintain Master, Working and End of Production Cell Banks. These cell banks are necessary steps in the production of the cells" then the volume will go way up
Needs some volume
regenerating-heart-tissue-stem-cell-therapy
http://www.mayo.edu/research/discoverys-edge/regenerating-heart-tissue-stem-cell-therapy
Miami Herald 2 days ago.
http://www.miamiherald.com/2014/04/09/4049899/scientists-try-3-d-printer-to.html
This is bloody
"Regarding Final Mandatory Conversion Date..." http://phoenix.corporate-ir.net/phoenix.zhtml?c=117098&p=irol-newsarticle&ID=1916950